Reseach of the Department of Microbiology


The main focus of the research

  • Neonatal infections: virulence markers of causative agents, optimization of neonatal sepsis treatment and prevention regimens; pharmacokinetics, pharmacodynamics and modeling of antibiotic therapy, clinical trials
  • HIV infection in Estonia: prevalence in populations, viral resistance markers, the relationship between the virus and the host, co-infections, human and viral genetic factors influencing HIV infection
  • Human microbiome from birth to death and its link to health: microbial communities in the gastrointestinal and reproductive tract, mouth and skin; their disorders in various infectious and non-infectious diseases
  • Biotechnological solutions for health: development of novel probiotics and synbiotics in laboratory and clinical trials
  • Antibiotic resistance: prevalence of resistance, factors influencing the development of resistance, prevention of the development of resistance, rational use of antibiotics
  • Monitoring of vaccine-preventable diseases: epidemiological changes over time, modeling




Current most important cooperation

In Estonia – various institutions and clinics of Tartu University Hospital (men's clinic, women's clinic, surgery clinic, children's clinic, dermatology clinic, internal clinic, dental clinic, ear clinic, joint laboratory, infection control service), UT BSMI Department of Biochemistry, UT Institute of Ecology and Earth Sciences, UT Estonian Gene Bank, UT Chair of Social Policy in the field of social sciences, UT Institute of Physics, Tallinn University of Technology, Tallinn University, East Tallinn Central Hospital, West Tallinn Central Hospital, North Estonian Regional Hospital, Institute for Health Development, Estonian University of Life Sciences.

Internationally – Cargill Europe (Belgium); Probi AB (Sweden); University of Turku (Finland); Karolinska Institutet (Sweden); University of Granada (Spain); University Colleage of London, Great Ormond Street Hospital, London (UK); Penta Foundation (Italy); c4c Network; The BARN and enilabAMR network includes clinics in many European countries as part of an international drug resistance study.

Entrepreneurship – Synlab Eesti OÜ, Tere AS, Tervisetehnoloogiate Arenduskeskus AS, BioCC OÜ, Food and Fermentation Technology Development Center, Perfect Cosmetics OÜ, Andre Juustufarm OÜ.


Data and biomaterial collections


Career conference „To new hights with a PhD degree!“

Teaduskonverentsi publik

Call for abstracts: scientific conference celebrating the anniversary of the Faculty of Medicine

 Tartu Ülikooli bio- ja siirdemeditsiini instituudi inimese geneetika õppetooli uuring koostöös Tartu Ülikooli Kliinikumi meestekliinikuga näitas, et üllatavalt suurel osal viljatutest meestest on lapsena diagnoositud munandi laskumishäire. Õigeaegne sekkumine aitab tulevikus lahendada viljatusprobleeme ja ennetada haruldaste kasvajate riski.

Testicular maldescent in infertile men may be a sign of a more severe genetic syndrome